NanoViricides Inc (NYSEMKT:NNVC) was downgraded by BidaskClub from a “sell” rating to a “strong sell” rating in a research report issued on Saturday.

Shares of NanoViricides (NNVC) opened at $1.02 on Friday. NanoViricides has a one year low of $0.91 and a one year high of $1.64.

TRADEMARK VIOLATION NOTICE: This piece was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The legal version of this piece can be accessed at

NanoViricides Company Profile

NanoViricides, Inc is a nano-biopharmaceutical company. The Company is a development-stage company with several drugs in various stages of development. The Company focuses on its research and clinical programs on specific anti-viral therapeutics. The Company is engaged in the application of nanomedicine technologies to the issues of viral diseases.

Receive News & Ratings for NanoViricides Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoViricides Inc and related companies with's FREE daily email newsletter.